Is Salarius Pharmaceuticals, Inc. technically bullish or bearish?
As of August 25, 2025, Salarius Pharmaceuticals shows a shift from mildly bearish to mildly bullish, with mixed indicators: bearish weekly MACD and RSI, mildly bullish monthly MACD, bearish daily moving averages, and bullish On-Balance Volume, while significantly underperforming the S&P 500 with a year-to-date return of -83.48%.
As of 25 August 2025, the technical trend for Salarius Pharmaceuticals, Inc. has changed from mildly bearish to mildly bullish. However, the overall stance remains mixed. The weekly MACD and RSI are bearish, while the monthly MACD is mildly bullish, indicating some potential for upward movement. The moving averages are bearish on a daily basis, and the Dow Theory shows no trend weekly but is bearish monthly. Despite this, the On-Balance Volume (OBV) is bullish on both weekly and monthly time frames, suggesting accumulation.In terms of performance, the stock has significantly underperformed the S&P 500 across all observed periods, with a year-to-date return of -83.48% compared to the S&P 500's 12.22%. This stark contrast highlights the challenges facing the stock despite the recent trend change.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
